Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]F-AraG PK in Healthy and NSCLC Subjects
NCT04678440Phase 1Completed
- Sponsor
- University of California, Davis
- Start
- Mar 2021
- Primary completion
- Feb 2023
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms), sponsored by University of California, Davis. Primary endpoints: Whole-body Pharmacokinetics of [18F]F-AraG Physiologic Uptake in Various Healthy Tissues, Whole-body Pharmacokinetics of [18F]F-AraG Pathologic Uptake in Tumor Lesions Relative to Uptake in Background Tissues and 1 more. Started Mar 2021; status: completed.
Beyond the preview
Go deeper on NCT04678440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04678440.